|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.14 USD | +2.09% |
|
+4.51% | -12.61% |
| Apr. 18 | NeoGenomics, Inc. Announces Senior Leadership Promotions | CI |
| Apr. 18 | NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics | CI |
NeoGenomics, Inc. provided earnings guidance for the year 2024. For the year, the company expects consolidated revenue of $650 million to $660 million, net loss of $72 million to $66 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.61% | 1.81B | |
| -17.89% | 8.25B | |
| +39.20% | 3.57B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B | |
| -15.34% | 1.03B |
NEOGENOMICS, INC. 
